Mycobacterium Citations List: December 2024

Literature Citations

1. Treatment of Mycobacterium tuberculosis Infected Macrophages with Rifabutin Loaded Β-glucan Microparticles Induces Macroautophagy Mediated Bacillary Killing. Ahmad, F., N. Fatima, S. Ahmad, T.K. Upadhyay, P. Jain, M. Saeed, I. Ahmad, L.A. Al-Keridis, M. Khubaib, and R. Sharma. International Journal of Biological Macromolecules, 2024. 283(Pt 2): 137256. PMID[39528171].
[PubMed]. TB_12_2024.

2. Modular Total Synthesis and Antimycobacterial Activity of Rufomycins. Bedding, M.J., B.C. Forster, A.M. Giltrap, M.T. Stevens, L. Corcilius, W.J. Britton, and R.J. Payne. Organic Letters, 2024. 26(50): p. 10993-10998. PMID[39653016].
[PubMed]. TB_12_2024.

3. Unveiling the Antimycobacterial Potential of Novel 4-alkoxyquinolines: Insights into Selectivity, Mechanism of Action, and In Vivo Exposure. da Silva, F.F., J.D. Paz, R.S. Rambo, G.A. Gonçalves, M.N. Muniz, A. de Matos Czeczot, M.A. Perelló, A. Berger, L.C. González, L.S. Duarte, A.B. da Silva, C.A.S. Ferreira, S.D. de Oliveira, S. Moura, C.V. Bizarro, L.A. Basso, and P. Machado. Journal of Medicinal Chemistry, 2024. 67(24): p. 21781-21794. PMID[39630172]. PMCID[PMC11684019].
[PubMed]. TB_12_2024.

4. In Vitro and In Silico Insights into Antimicrobial and Anticancer Activities of Novel Imidazo[2,1-b][1,3,4]thiadiazoles. Dwarakanath, D., Y.N. Nayak, A. Kulal, S. Pandey, K.S.R. Pai, and S.L. Gaonkar. Scientific Reports, 2024. 14(1): 31994. PMID[39738776]. PMCID[PMC11685468].
[PubMed]. TB_12_2024.

5. TBAJ-587, a Novel Diarylquinoline, is Active Against Mycobacterium abscessus. Fan, J., Z. Tan, S. He, A. Li, Y. Jia, J. Li, Z. Zhang, B. Li, and H. Chu. Antimicrobial Agents and Chemotherapy, 2024. 68(12): e0094524. PMID[39470202]. PMCID[PMC11619292].
[PubMed]. TB_12_2024.

6. Structure-based Screening and Optimization of PafA Inhibitors with Potent Anti-tuberculosis Activity. Jiang, H., J. Xie, L. Wang, H. Chen, Y. Zheng, X. Wang, S. Guo, T. Wang, J. Bi, X. Zhang, J. Pei, and S. Tao. International Journal of Molecular Sciences, 2024. 25(23). PMID[39684899]. PMCID[PMC11642889].
[PubMed]. TB_12_2024.

7. Design, Synthesis, Anti-mycobacterial Activity, Molecular Docking and ADME Analysis of Spiroquinoxaline-1,2,4-oxadiazoles Via [3 + 2] Cycloaddition Reaction under Ultrasound Irradiation. Kanchrana, M., R.K. Gamidi, J. Kumari, D. Sriram, and S. Basavoju. Molecular Diversity, 2024. 28(6): p. 3979-3991. PMID[38261121].
[PubMed]. TB_12_2024.

8. Synthesis, Antimycobacterial and Antifungal Evaluation of New 4-(furan-2-ylmethyl)-6-methylpyridazin-3(2H)-ones. Karayavuz, B., S.K. Vagolu, D. Kart, T. Tonjum, and O. Unsal-tan. Journal of the Serbian Chemical Society, 2024. 89(11): p. 1423-1431. ISI[001374777300003].
[WOS]. TB_12_2024.

9. Design, Synthesis, Biological Evaluation Study of Spirocyclic Pom Analogues as Novel MmpL3 Anti-tubercular Agent. Mi Kim, Y., Y. Park, E. Soon Son, A. Lee, S. Bang, J. Eun Ahn, L. Cui, K. Kim, J. Seong Yang, S. Park, M. Kang, M. Ji Jeong, J. Whang, J. Seok Lee, and I. Choi. Bioorganic Chemistry, 2024. 153: 107823. PMID[39317038].
[PubMed]. TB_12_2024.

10. Identification of an Isoxazole Derivative as an Antitubercular Compound for Targeting the FadD Enzymes of Mycobacterium Tuberculosis. Rani, N., R.S. Rajmani, and A. Surolia. Journal of Medicinal Chemistry, 2024. ISI[001380426800001].
[WOS]. TB_12_2024.

11. Developing Novel Indoles as Antitubercular Agents and Simulated Annealing-based Analysis of Their Binding with MmpL3. Ray, R., S. Das, S.R. Birangal, H.I. Boshoff, J.S. Roma, M. Lobo, R.C. Hariharapura, and G.G. Shenoy. Future Med Chem, 2025. 17(1): p. 19-34. PMID[39720921].
[PubMed]. TB_12_2024.

12. Cyclophostin and Cyclipostins Analogues Counteract Macrolide-induced Resistance Mediated by Erm(41) in Mycobacterium abscessus. Sarrazin, M., I. Poncin, P. Fourquet, S. Audebert, L. Camoin, Y. Denis, P. Santucci, C.D. Spilling, L. Kremer, V. Le Moigne, J.L. Herrmann, J.F. Cavalier, and S. Canaan. Journal of Biomedical Science, 2024. 31(1): 103. PMID[39623375]. PMCID[PMC11613490].
[PubMed]. TB_12_2024.

13. Biosynthesis of Silver, Copper, and Their Bi-metallic Combination of Nanocomposites by Staphylococcus aureus: Their Antimicrobial, Anticancer Activity, and Cytotoxicity Effect. Sayed, M.A., T. El-Rahman, H.K. Abdelsalam, S. El-Souad, R.M. Shady, R.A. Amen, M.A. Zaki, M. Mohsen, S. Desouky, S. Saeed, S. Omar, and A.A.H. El-Bassuony. Indian Journal of Microbiology, 2024. 64(4): p. 1721-1737. PMID[39678971]. PMCID[PMC11645382].
[PubMed]. TB_12_2024.

14. Evaluation of Tridax Procumbens Secondary Metabolites Anti-tuberculosis Activity by In Vitro and In Silico Methods. Seetharaman, J., R.A. Priya, R.R. Philip, M. Muthuraj, and D. Sankari. Current Microbiology, 2024. 82(1): 50. PMID[39702691].
[PubMed]. TB_12_2024.

15. Thymol as Biofilm and Efflux Pump Inhibitor: A Dual-action Approach to Combat Mycobacterium tuberculosis. Shankar Das, B., A. Sarangi, I. Pahuja, V. Singh, S. Ojha, S. Giri, A. Bhaskar, and D. Bhattacharya. Cell Biochemistry & Function, 2024. 42(8): e70030. PMID[39676255].
[PubMed]. TB_12_2024.

16. Structure-based Drug Design and Characterization of Novel Pyrazine Hydrazinylidene Derivatives with a Benzenesulfonate Scaffold as Noncovalent Inhibitors of DprE1 Tor Tuberculosis Treatment. Shivakumar, P. Dinesha, and D. Udayakumar. Molecular Diversity, 2024. 28(6): p. 4221-4239. PMID[38448719].
[PubMed]. TB_12_2024.

17. Indole Triazene Compound TU112 Demonstrates In Vitro Activity against Dormant Mycobacterium tuberculosis and Efficacy against Chronic Tuberculosis Infection in Mice. Shleeva, M.O., B.V. Nikonenko, K.B. Majorov, P.Y. Ivanov, A.S. Apt, and V.S. Velezheva. Tuberculosis, 2024. 149: 102556. PMID[39226860].
[PubMed]. TB_12_2024.

18. Recent Cutting-edge Designing Strategies for Mtb-DHFR Inhibitors as Antitubercular Agents. Sonawane, N.G., A. Thakur, A.K.S. Pillai, A. Sharma, A.P. Gunjal, and K. Sharma. Chemical Biology & Drug Design, 2024. 104(6): e70027. PMID[39660864].
[PubMed]. TB_12_2024.

19. Synthesis, Characterization, and Biological Activity of Some Lanthanide Complexes with (E)- (E)-N'-(3,5- di-tert-butyl-2-hydroxybenzylidene)picolinohydrazide: Solid-state Molecular Structure of [DyL(NO3)DMF]2. Taha, Z.A., A.K. Hijazi, H. Abul-Futouh, W. Al Momani, B.M. Alziqili, P. Liebing, and W. Weigand. Journal of Molecular Structure, 2024. 1316: 139054. ISI[001368409200001].
[WOS]. TB_12_2024.

20. Phenotypic-based Discovery and Exploration of a Resorufin Scaffold with Activity against Mycobacterium tuberculosis. Tran, E., C.Y. Cheung, L. Li, G.P. Carter, R.W. Gable, N.P. West, A. Kaur, Y.S. Gee, G.M. Cook, J.B. Baell, and M. Jörg. ChemMedChem, 2024. 19(24): e202400482. PMID[39248310]. PMCID[PMC11648835].
[PubMed]. TB_12_2024.

21. Phytocompounds Hesperidin, Rebaudioside a and Rutin as Drug Leads for the Treatment of Tuberculosis Targeting Mycobacterial Phosphoribosyl Pyrophosphate Synthetase. Vysyan, S.M., M.S. Prasanna, A. Jayanandan, A.K. Gangadharan, and S. Chittalakkottu. Journal of Biomolecular Structure & Dynamics, 2024. ISI[001374871000001].
[WOS]. TB_12_2024.

22. Drug Repurposing: An Antidiabetic Drug Ipragliflozin as Mycobacterium tuberculosis Sirtuin-like Protein Inhibitor That Synergizes with Anti-tuberculosis Drug Isoniazid. Zhen, J., C. Zhang, T. Huang, L. Xie, Y. Yan, S. Yan, J. Zhang, H. Huang, and J. Xie. International Journal of Biological Macromolecules, 2024. 282(Pt 3): 137003. PMID[39481722].
[PubMed]. TB_12_2024.

23. Design, Synthesis and Antimycobacterial Activity of Novel Benzothiazinones with Improved Water Solubility. Zhong, X., J. Wu, N. Du, S. Zhou, C. Ma, T. Xue, M. Wei, J. Gong, B. Wang, M. Liu, A. Wang, K. Lv, and Y. Lu. European Journal of Medicinal Chemistry, 2024. 279: 116829. PMID[39243457].
[PubMed]. TB_12_2024.

Patent Citations

24. Preparation of Substituted Thieno[2,3-D]Thiazole-5-Carboxamides and Their Use in the Treatment of Tuberculosis and Mycobacterial Infections. Bates, R., L. Cleghorn, S. Davis, K. Green, S. Green, J. Harrison, E. Jimenez Navarro, P. Koovits, and P. Wyatt. Patent. 2024. WO2024-EP664022024256554: 66 pp.
[Patent]. TB_12_2024.

25. Preparation of Azetidines, Compositions and Methods for Treating Tuberculosis. Nag, P.P. Patent. 2024. WO2024-US325492024254148: 135 pp.
[Patent]. TB_12_2024.